Acta Pharmaceuticals has secured US$24m in seed funding to develop experimental treatments aimed at early intervention in Alzheimer's disease. 🔗 Full story: buff.ly/J6Btky5 #Type2Diabetes #DiabetesTreatment #InsulinTherapy #DrugApproval #HealthcareInnovation

Ascensia and Sava have partnered to develop a less invasive glucose monitor that could become available in Europe within the next two years. 🔗 Full story: buff.ly/i3oz3yQ #Diabetes #GlucoseMonitoring #WearableTechnology #Medtech #HealthcareInnovation

The MHRA has authorised once-weekly insulin for adults with type 2 diabetes, potentially reducing injections from up to 365 a year to 52. 🔗 Full story: buff.ly/Yd4GUz6 #Type2Diabetes #DiabetesTreatment #InsulinTherapy #DrugApproval #HealthcareInnovation

TWENTY years after cells were reprogrammed in a petri-dish, the first human trial to reverse cellular ageing is showing promising initial results. 🔗 Full story: buff.ly/0OeVKbs #Longevity #AntiAgeing #ClinicalTrials #CellularReprogramming #HealthyAgeing

Exercise reduced Alzheimer's-like brain changes and improved memory in older mice after six weeks, a study suggests. 🔗 Full story: buff.ly/VcyModD #Alzheimers #DementiaResearch #Exercise #BrainHealth #HealthyAgeing

An AI tool can detect ageing in blood stem cells by analysing the three-dimensional organisation of DNA, researchers report. 🔗 Full story: buff.ly/oEyp6Ej #StemCells #ArtificialIntelligence #Longevity #AgeingResearch #HealthyAgeing

Jonathan's DNA has revealed genetic variants and chemical patterns that could offer clues to the longevity of the world's oldest living land animal. 🔗 Full story: buff.ly/kMQxQWp #Longevity #HealthyAgeing #Genetics #AgeingResearch #Science

A biotech developing a new type of Parkinson’s therapy has signed a licensing deal with Roche’s Genentech worth up to US$1.27bn. 🔗 Full story: buff.ly/m8TOO8g #Parkinsons #DrugDevelopment #Biotech #Neurodegeneration #AgeTech

People who are overweight or obese when diagnosed with dementia have a lower risk of death than those of normal weight, a study suggests. 🔗 Full story: buff.ly/mCoMM4D #Dementia #Obesity #HealthyAgeing #Nutrition #DementiaResearch

Scientists in the US are developing an AI system that interprets nonverbal communication and translates it into information caregivers can understand. 🔗 Full story: buff.ly/mgAF3AF #ArtificialIntelligence #AssistiveTechnology #Disability #Caregiving #HealthTech

The success of the fat-busting GLP-1 drug has supercharged the global peptide market which now has a valuation upwards of $100bn. 🔗 Full story: buff.ly/wWSq7pm #Peptides #GLP1 #Longevity #HealthyAgeing #Biohacking

British startup InTouchNow has raised £2.3m in seed funding to develop its AI voice agent for GP phone lines, which can detect patient frustration. 🔗 Full story: buff.ly/OeCMbAj #HealthTech #ArtificialIntelligence #PrimaryCare #NHS #DigitalHealth

London healthtech Lottie has acquired care billing specialist CareMaster, which provides software to 750+ UK care homes. 🔗 Full story: buff.ly/NNqMcWZ #CareTech #SocialCare #CareHomes #HealthTech #CareSoftware

Glucosamine use was linked to a higher dementia progression risk among people with mild cognitive impairment, a study suggests. 🔗 Full story: buff.ly/VIv443i #Alzheimers #Dementia #Glucosamine #BrainHealth #HealthyAgeing

Semaglutide heart benefits cannot be fully explained by weight loss or improvements in other known risk factors, a new analysis suggests. 🔗 Full story: buff.ly/izN6Ae8 #Semaglutide #HeartHealth #CardiovascularHealth #GLP1 #Research

More than 250,000 UK adults are being recruited for a study investigating why early bowel cancer rates are rising among people under 50. 🔗 Full story: buff.ly/0DSGmjB #BowelCancer #CancerResearch #EarlyOnsetCancer #HealthyAgeing #Research

Averly Health has launched a UK cardiometabolic care service combining clinical assessment, prescribing, pharmacy and long-term patient support. 🔗 Full story: buff.ly/juYHcaB #CardiometabolicCare #Diabetes #ChronicDisease #Healthcare #HealthyAgeing

Monkeys with induced Alzheimer's-like brain changes showed no memory loss a year later, potentially offering clues to protective mechanisms. 🔗 Full story: buff.ly/iyqCTlF #AlzheimersDisease #DementiaResearch #BrainHealth #MemoryLoss #HealthyAgeing

Danish biotech Breye Therapeutics has raised €67.5m to advance an oral drug for diabetic eye disease into a Phase 2 trial. 🔗 Full story: buff.ly/fiLqwEV #DiabeticEyeDisease #DiabeticRetinopathy #DrugDevelopment #Biotech #HealthInvestment

Swedish drug developer AnaCardio has raised US$70.9m in a Series B round to fund the next phase of its oral heart failure drug trials. 🔗 Full story: buff.ly/KEX2QvF #HeartFailure #AnaCardio #DrugDevelopment #ClinicalTrials #HealthInvestment